NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email A new NESO assessment warns that the UK could face emerging gas supply risks in the 2030s as domestic production collapses and dependence on imports grows, especially under peak-demand winter scenarios.Read More